Search Results

There are 36144 results for: content related to: A Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials of Milnacipran Monotherapy in the Treatment of Fibromyalgia

  1. Milnacipran versus other antidepressive agents for depression

    Intervention Review

    The Cochrane Library

    Atsuo Nakagawa, Norio Watanabe, Ichiro M Omori, Corrado Barbui, Andrea Cipriani, Hugh McGuire, Rachel Churchill and Toshi A Furukawa

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD006529.pub2

  2. You have free access to this content
    Milnacipran for pain in fibromyalgia in adults

    Intervention Review

    The Cochrane Library

    Malene Cording, Sheena Derry, Tudor Phillips, R Andrew Moore and Philip J Wiffen

    Published Online : 20 OCT 2015, DOI: 10.1002/14651858.CD008244.pub3

  3. Effects of Milnacipran on Cardiac Repolarization in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 422–433, Antonia Periclou, Robert H. Palmer, Hongjie Zheng and Charles Lindamood III

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009346059

  4. You have free access to this content
    Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain

    British Journal of Pharmacology

    Volume 167, Issue 3, October 2012, Pages: 537–547, S Ohnami, A Kato, K Ogawa, S Shinohara, H Ono and M Tanabe

    Version of Record online : 5 SEP 2012, DOI: 10.1111/j.1476-5381.2012.02007.x

  5. You have free access to this content
    Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 62, Issue 9, September 2010, Pages: 2745–2756, Lesley M. Arnold, R. Michael Gendreau, Robert H. Palmer, Judy F. Gendreau and Yong Wang

    Version of Record online : 21 MAY 2010, DOI: 10.1002/art.27559

  6. Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study

    Pain Medicine

    Volume 11, Issue 2, February 2010, Pages: 180–194, Don L. Goldenberg, Daniel J. Clauw, Robert H. Palmer, Philip Mease, Wei Chen and R. Michael Gendreau

    Version of Record online : 9 DEC 2009, DOI: 10.1111/j.1526-4637.2009.00755.x

  7. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome

    Intervention Review

    The Cochrane Library

    Winfried Häuser, Gerard Urrútia, Sera Tort, Nurcan Üçeyler and Brian Walitt

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD010292

  8. You have free access to this content
    Milnacipran influences the indexes of I-metaiodobenzylguanidine scintigraphy in elderly depressed patients

    Psychiatry and Clinical Neurosciences

    Volume 68, Issue 3, March 2014, Pages: 169–175, Katsutoshi Yokoyama, Takeshi Yamada, Sayaka Terachi, Shenghong Pu, Yasutoshi Ohta, Takehiko Yamanashi, Hiroshi Matsumura, Kazuyuki Nakagome and Koichi Kaneko

    Version of Record online : 31 OCT 2013, DOI: 10.1111/pcn.12111

  9. You have free access to this content
    Milnacipran, a Well-Tolerated Specific Serotonin and Norepinephrine Reuptake Inhibiting Antidepressant

    CNS Drug Reviews

    Volume 4, Issue 2, June 1998, Pages: 137–148, M. Briley

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.1998.tb00060.x

  10. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression

    Acta Psychiatrica Scandinavica

    Volume 96, Issue 6, December 1997, Pages: 497–504, E. Leinonen, U. Lepola, H. Koponen, O.-P. Mehtonen and R. Rimon

    Version of Record online : 13 NOV 2007, DOI: 10.1111/j.1600-0447.1997.tb09953.x

  11. Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI)

    Human Psychopharmacology: Clinical and Experimental

    Volume 12, Issue S3, September 1997, Pages: S127–S134, Y. Lecrubier

    Version of Record online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199709)12:3+<S127::AID-HUP943>3.0.CO;2-X

  12. Specific serotonin and noradrenaline reuptake inhibitors (SNRIs). A review of their pharmacology, clinical efficacy and tolerability

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue 2, March 1998, Pages: 99–111, M. Briley

    Version of Record online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199803)13:2<99::AID-HUP954>3.0.CO;2-2

  13. No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery

    European Journal of Pain

    P. Okkerse, R. Alvarez-Jimenez, J.L. Hay, A. Tehim, R. Kumar, M.L. de Kam and G.J. Groeneveld

    Version of Record online : 21 SEP 2016, DOI: 10.1002/ejp.943

  14. You have free access to this content
    Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?

    British Journal of Pharmacology

    Volume 163, Issue 4, June 2011, Pages: 792–803, A-S Wattiez, F Libert, A-M Privat, S Loiodice, J Fialip, A Eschalier and C Courteix

    Version of Record online : 26 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01297.x

  15. You have free access to this content
    Piloerection induced by replacing fluvoxamine with milnacipran

    British Journal of Clinical Pharmacology

    Volume 63, Issue 6, June 2007, Pages: 665–671, Satoko Hori, Nobuko Matsuo, Akiko Yamamoto, Tomomi Hazui, Hiromi Yagi, Marumi Nakano, Yuka Suzuki, Akiko Miki, Hisakazu Ohtani and Yasufumi Sawada

    Version of Record online : 23 FEB 2007, DOI: 10.1111/j.1365-2125.2006.02838.x

  16. Milnacipran: an antidepressant with dual selectivity of action on noradrenaline and serotonin uptake

    Human Psychopharmacology: Clinical and Experimental

    Volume 15, Issue 4, June 2000, Pages: 255–260, A Delini-Stula

    Version of Record online : 4 JUL 2000, DOI: 10.1002/1099-1077(200006)15:4<255::AID-HUP165>3.0.CO;2-V

  17. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

    Human Psychopharmacology: Clinical and Experimental

    Volume 19, Issue S1, October 2004, Pages: S27–S35, Olivier Vitton, Michael Gendreau, Judy Gendreau, Jay Kranzler and Srinivas G. Rao

    Version of Record online : 20 SEP 2004, DOI: 10.1002/hup.622

  18. You have free access to this content
    Pharmacodynamics of milnacipran in young and elderly volunteers

    British Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2000, Pages: 118–125, I. Hindmarch, U. Rigney, N. Stanley and M. Briley

    Version of Record online : 5 APR 2002, DOI: 10.1046/j.1365-2125.2000.00124.x

  19. Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients

    Human Psychopharmacology: Clinical and Experimental

    Volume 4, Issue 3, September 1989, Pages: 221–227, M. Ansseau, R. Von Frenckell, P. Papart, C. Mertens, J. De Wilde, L. Botte, J.-M. Devoitille, J.-L. Evrard, A. De Nayer, S. Koch-Bourdouxhe, P. Darimont, A. Lecoq, J. Mirel, J. P. Couzinier, J.-P. Demarez and C. Serre

    Version of Record online : 13 OCT 2004, DOI: 10.1002/hup.470040308

  20. You have free access to this content
    Effects of Milnacipran and Pindolol on Extracellular Noradrenaline and Serotonin Levels in Guinea Pig Hypothalamus

    Journal of Neurochemistry

    Volume 69, Issue 2, August 1997, Pages: 815–822, Chantal Moret and Mike Briley

    Version of Record online : 18 NOV 2002, DOI: 10.1046/j.1471-4159.1997.69020815.x